{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "25894075", "DateCompleted": {"Year": "2016", "Month": "04", "Day": "01"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "04", "Day": "19"}], "ELocationID": ["10.1007/s11418-015-0913-9"], "Language": ["eng"], "Journal": {"ISSN": "1861-0293", "JournalIssue": {"Volume": "69", "Issue": "4", "PubDate": {"Year": "2015", "Month": "Oct"}}, "Title": "Journal of natural medicines", "ISOAbbreviation": "J Nat Med"}, "ArticleTitle": "Antinociceptive and anti-inflammatory effects of myricetin 3-O-\u03b2-galactoside isolated from Davilla elliptica: involvement of the nitrergic system.", "Pagination": {"StartPage": "487", "EndPage": "493", "MedlinePgn": "487-93"}, "Abstract": {"AbstractText": ["We aimed to study the antinociceptive effects of myricetin 3-O-\u03b2-galactoside (Mi), a substance isolated from the hydroalcoholic extract of Davilla elliptica. This study examined male Swiss mice, inducible nitric oxide synthase C57B16/J knockout mice (iNOS(-/-)), and their corresponding wild type (WT). Formalin and tail-flick tests were used to evaluate the nociceptive threshold, and the carrageenan-induced paw edema test was used as a model for inflammation. The following drugs were administered to investigate the involvement of the nitrergic and opioidergic systems: L-NAME, a nonspecific nitric oxide synthase (NOS) inhibitor; L-arginine (L-Arg), a precursor for the synthesis of nitric oxide (NO); D-arginine (D-Arg), an inactive isomer for the synthesis of NO; aminoguanidine (Am), an inducible nitric oxide synthase (iNOS) inhibitor; and naloxone, a nonselective antagonist of opioid receptors. The results showed that oral pretreatment with Mi caused a dose-dependent inhibition of the inflammatory phase of the formalin test and did not alter motor performance. Intraperitoneal injection of L-NAME caused a reduction in the licking time during the second phase of the formalin test. The administration of L-Arg (but not D-Arg) reversed the antinociceptive effect of L-NAME. Furthermore, pre-administration of aminoguanidine potentiated the antinociceptive effect. Mi did not cause an antinociceptive effect in iNOS knockouts and led to a reduction in the nitrite concentration in the paws of mice. Carrageenan-induced paw edema was reduced in Swiss mice and WT mice when compared to iNOS(-/-) mice. Pre-administration of naloxone (NLX) did not reverse the antinociceptive effect of Mi, excluding the opioidergic system as a mediator of the antinociceptive effect. Thus, the results suggest that the antinociceptive and anti-inflammatory effects of myricetin 3-O-\u03b2-galactoside are related to peripheral inhibition of nitric oxide synthesis, mainly iNOS."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Pain and Analgesia, Department of Pharmacology, Institute of Biological Sciences, Federal University of Minas Gerais (UFMG), Av. Presidente Ant\u00f4nio Carlos, 6627, Pampulha, Belo Horizonte, Minas Gerais, 31270-010, Brazil."}], "LastName": "Azevedo", "ForeName": "Adolfo de Oliveira", "Initials": "Ade O"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Campos", "ForeName": "Jussara J\u00falia", "Initials": "JJ"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "de Souza", "ForeName": "Giovane Galdino", "Initials": "GG"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Veloso", "ForeName": "Clarice de Carvalho", "Initials": "Cde C"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Duarte", "ForeName": "Igor Dimitri Gama", "Initials": "ID"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Braga", "ForeName": "Fern\u00e3o Castro", "Initials": "FC"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Perez", "ForeName": "Andrea de Castro", "Initials": "Ade C"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "J Nat Med", "NlmUniqueID": "101518405", "ISSNLinking": "1340-3443"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Analgesics"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Galactosides"}, {"RegistryNumber": "0", "NameOfSubstance": "myricetin-3-O-galactoside"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}], "MeshHeadingList": [{"QualifierName": ["metabolism"], "DescriptorName": "Analgesics"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["metabolism"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Edema"}, {"QualifierName": ["chemistry"], "DescriptorName": "Galactosides"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Mice, Knockout"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Fed Proc. 1987 Jan;46(1):118-26", "ArticleIdList": ["3100339"]}, {"Citation": "PLoS One. 2009 Oct 29;4(10):e7596", "ArticleIdList": ["19893614"]}, {"Citation": "Pain. 1989 Sep;38(3):347-52", "ArticleIdList": ["2478947"]}, {"Citation": "Br J Pharmacol. 1995 Jan;114(2):323-8", "ArticleIdList": ["7533614"]}, {"Citation": "Nature. 1988 Jun 16;333(6174):664-6", "ArticleIdList": ["3131684"]}, {"Citation": "Naunyn Schmiedebergs Arch Pharmacol. 1999 Mar;359(3):220-7", "ArticleIdList": ["10208309"]}, {"Citation": "Chem Phys Lipids. 1998 Dec;97(1):79-85", "ArticleIdList": ["10081150"]}, {"Citation": "Adv Immunol. 1995;60:323-71", "ArticleIdList": ["8607373"]}, {"Citation": "Br J Pharmacol. 1991 Jan;102(1):198-202", "ArticleIdList": ["2043923"]}, {"Citation": "Pharmacol Rev. 2001 Dec;53(4):597-652", "ArticleIdList": ["11734620"]}, {"Citation": "J Ethnopharmacol. 2007 Sep 5;113(2):354-6", "ArticleIdList": ["17692484"]}, {"Citation": "Br J Pharmacol. 1993 Sep;110(1):219-24", "ArticleIdList": ["7693278"]}, {"Citation": "Nature. 2000 Feb 24;403(6772):853-8", "ArticleIdList": ["10706275"]}, {"Citation": "Arch Pharm Res. 2009 Apr;32(4):527-33", "ArticleIdList": ["19407970"]}, {"Citation": "Br J Pharmacol. 1993 Sep;110(1):193-8", "ArticleIdList": ["8220879"]}, {"Citation": "Anesthesiology. 2004 Oct;101(4):983-90", "ArticleIdList": ["15448533"]}, {"Citation": "Anesthesiology. 2000 Jul;93(1):173-8", "ArticleIdList": ["10861161"]}, {"Citation": "Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13525-30", "ArticleIdList": ["17686976"]}, {"Citation": "Pain. 1977 Dec;4(2):161-74", "ArticleIdList": ["564014"]}, {"Citation": "Phytochem Anal. 2008 Jan-Feb;19(1):17-24", "ArticleIdList": ["17654510"]}, {"Citation": "Neuropharmacology. 1992 Mar;31(3):251-8", "ArticleIdList": ["1630593"]}, {"Citation": "Front Neurosci. 2009 Sep 15;3(2):175-81", "ArticleIdList": ["20011139"]}, {"Citation": "Eur J Immunol. 1995 Apr;25(4):947-51", "ArticleIdList": ["7737298"]}, {"Citation": "Pain. 1992 Oct;51(1):5-17", "ArticleIdList": ["1454405"]}, {"Citation": "Gen Pharmacol. 1997 Aug;29(2):121-6", "ArticleIdList": ["9251891"]}, {"Citation": "Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6368-71", "ArticleIdList": ["1648740"]}, {"Citation": "Braz J Med Biol Res. 1987;20(2):243-9", "ArticleIdList": ["3690058"]}, {"Citation": "Anal Biochem. 1982 Oct;126(1):131-8", "ArticleIdList": ["7181105"]}, {"Citation": "Eur J Pharmacol. 1991 Jul 9;199(3):379-81", "ArticleIdList": ["1915585"]}, {"Citation": "Agents Actions. 1991 Sep;34(1-2):264-9", "ArticleIdList": ["1665298"]}, {"Citation": "J Ethnopharmacol. 2013 Oct 28;150(1):270-4", "ArticleIdList": ["24001889"]}, {"Citation": "J Neurosci Methods. 1985 Jun;14(1):69-76", "ArticleIdList": ["4033190"]}, {"Citation": "Eur J Pharmacol. 1990 Dec 4;191(3):481-4", "ArticleIdList": ["1707819"]}, {"Citation": "J Am Pharm Assoc Am Pharm Assoc. 1957 Mar;46(3):208-9", "ArticleIdList": ["13502156"]}, {"Citation": "Trends Biotechnol. 1995 Feb;13(2):70-8", "ArticleIdList": ["7535060"]}, {"Citation": "Eur J Pharmacol. 2004 May 25;492(2-3):117-22", "ArticleIdList": ["15178354"]}, {"Citation": "Pain. 1983 Jun;16(2):109-10", "ArticleIdList": ["6877845"]}], "ReferenceList": []}], "History": [{"Year": "2014", "Month": "7", "Day": "21"}, {"Year": "2015", "Month": "4", "Day": "6"}, {"Year": "2015", "Month": "4", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "4", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "4", "Day": "2", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["25894075", "10.1007/s11418-015-0913-9"]}}], "PubmedBookArticle": []}